Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?

Nguyen, Ha T; Tian, Geng; Murph, Mandi M

Nguyen, Ha T; Tian, Geng; Murph, Mandi M.

Afiliação

Nguyen HT; Department of Pharmaceutical and Biomedical Sciences, University of Georgia College of Pharmacy , Athens, GA , USA.
Tian G; Department of Pharmaceutical and Biomedical Sciences, University of Georgia College of Pharmacy , Athens, GA , USA ; Department of Obstetrics and Gynecology, The Second Hospital of Jilin University , Changchun , China.
Murph MM; Department of Pharmaceutical and Biomedical Sciences, University of Georgia College of Pharmacy , Athens, GA , USA.

Front Oncol ; 4: 71, 2014.

Article em En | MEDLINE | ID: mdl-24782983

Palavras-chave

DNA methylation; epigenetics; histone modifications; microRNA; ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google